Figma Inc. Class A Common Stock vs Medtronic PLC — how do they compare? Figma Inc. Class A Common Stock trades at $21.21 (market cap $11.60B), while Medtronic PLC trades at $95 (market cap $118.97B). The key difference: Medtronic PLC is far larger — about 10.3× Figma Inc. Class A Common Stock's market cap, and Medtronic PLC pays a 3.1% dividend while Figma Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Figma Inc. Class A Common Stock for 0 Days and Medtronic PLC for 63 Days on average.
| FIG | MDT | |
|---|---|---|
Market Cap | $11.60B | $118.97B |
Volume | 12,281,013 | 24,932,018 |
Sector | Technology | Health |
52-Week High | $63.82 | $105.35 |
52-Week Low | $16.84 | $73.75 |
Typical Hold Time | 0 Days | 63 Days |
Enterprise Value | $10.00B | $138.31B |
Dividend Yield | — | 3.1% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Medtronic (MDT) trades at $94.23, up 2.5% with strong technical momentum near resistance at $95. The stock shows solid fundamentals with consistent earnings beats, 13.93% net margins, and a 49-year dividend growth streak. Recent CPT code approvals for medical devices and raised 2026 guidance signal operational strength. Technical indicators show bullish moving averages but RSI suggests potential overbought conditions near-term.
MDT offers value with 3.2% dividend yield and 7%+ revenue growth, though debt levels have risen to 31.1% of assets. Analyst consensus remains strongly bullish (61% buy ratings) with $97.73 price target. Key risks include execution of the MiniMed separation and medical device competition. The stock presents a balanced opportunity for income and growth investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Figma, Inc. is a US software company that operates a collaborative interface design and product development platform used by design and engineering teams to create, prototype, and build digital products.
Read more on FIG →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →